A bicalutamide pharmaceutical composition having a high content of bicalutamide is provided.
A method of crystallizing bicalutamide, comprising adding an acetone solution containing bicalutamide to water.
The composition can be made from micronized bicalutamide, in order to enhance the speed of dissolution and is preferably made from a granulate of bicalutamide that contains at least 50 (w/w)% of bicalutamide
Bicalutamide form II is useful as a pharmaceutical and has antiandrogenic activity.
A new crystalline form of bicalutamide (form II) is disclosed.
The present invention discloses a new process for the isolation and purification of racemic and optically active bicalutamide.
BICALUTAMIDE blocks the effect of the male hormone called testosterone.
Steroidal and non-steroidal antiandrogens are suitable.
A method for purifying the Bicalutamide using ethyl acetate solvent resulting in the product, substantially free from process related impurities A, B, C and D, and the crystalline form of Bicalutamide are also disclosed.
Administration of bicalutamide may lead to inhibition of spermatogenesis.
In clinical study the mean concentration of R-bicalutamide in semen of men receiving bicalutamide 150 mg was 4.9 µg/ml.
Bicalutamide is used in combination with another medicine
One suitable antiandrogen is bicalutamide.
No separate frequency descriptor can therefore be determined for the 150 mg bicalutamide dose however the same frequency as the 50 mg dose is assumed.
In clinical study the mean concentration of R-bicalutamide in semen of men receiving bicalutamide 150 mg was 4.9 µg/ml.
No separate frequency descriptor can therefore be determined for the 150 mg bicalutamide dose however the same frequency as the 50 mg dose is assumed.
A tablet comprising bicalutamide and a method for its production.
The invention also provides methods for their preparation and pharmaceutical compositions containing the new forms of bicalutamide.
In a clinical study the mean concentration of R-bicalutamide in semen of men receiving Casodex 150 mg was 4.9 microgram/ml.
Administration of CASODEX may lead to inhibition of spermatogenesis.
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод